SavedAdd your journal

Journals / İstanbul Tıp Fakültesi Dergisi / 2026 / Cilt: 89 Sayı: 2

COMBINED EFFECTS OF RETINOIC ACID AND SELENIUM ON CELL VIABILITY IN SH-SY5Y NEUROBLASTOMA CELLS

Berna Yıldırım(ISTANBUL ATLAS UNIVERSITY)0000-0002-4479-2586
Burcu Biltekin(ISTANBUL ATLAS UNIVERSITY)0000-0002-8435-6797
Melike Seçilmiş(ISTANBUL ATLAS UNIVERSITY)0000-0002-0749-1821
Ayhan Bilir(İstanbul Atlas Üniversitesi)0009-0009-9399-5927
Pages
127–131
Publication Date
2026-05-13
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These findings indicate that the simultaneous application of RA and Se can elicit a stronger cytotoxic effect in SH-SY5Y cells than either treatment alone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the individual and combined effects of retinoic acid (RA) and selenium (Se) on cell viability in SH-SY5Y neuroblastoma cells, with a focus on dose- and time-dependent responses.
📊
Key Findings & Data:Materials and Methods: SH-SY5Y cells were treated with varying concentrations of RA (1, 10, or 100 μM) and Se (1, 10, or 100 μM), either alone or in combination.
💡
Conclusion & Impact:Conclusion: These findings indicate that the simultaneous application of RA and Se can elicit a stronger cytotoxic effect in SH-SY5Y cells than either treatment alone.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Retinoic acid (RA) · Selenium (Se) · SH-SY5Y

Abstract

Objective: This study aimed to investigate the individual and combined effects of retinoic acid (RA) and selenium (Se) on cell viability in SH-SY5Y neuroblastoma cells, with a focus on dose- and time-dependent responses. Materials and Methods: SH-SY5Y cells were treated with varying concentrations of RA (1, 10, or 100 μM) and Se (1, 10, or 100 μM), either alone or in combination. Cell viability was assessed using the trypan blue exclusion assay at 48 and 72 hours. Statistical analyses were performed using one-way or two-way ANOVA followed by Dunnett’s post hoc test, as appropriate. Results: Retinoic acid significantly reduced cell viability in a dose-dependent manner at both time points, with 100 μM RA causing near-complete loss of viable cells. Selenium also decreased viability, but its effect was milder and became significant only at higher concentrations. Notably, the combined application of RA and Se produced a substantially stronger cytotoxic effect than either agent alone, indicating a potential synergistic or additive interaction between the two. Conclusion: These findings indicate that the simultaneous application of RA and Se can elicit a stronger cytotoxic effect in SH-SY5Y cells than either treatment alone. The results highlight the importance of redox modulation and combination strategies in neuroblastoma cell models. Further studies are warranted to elucidate the underlying mechanisms and therapeutic potential of RA and Se co-treatment.

🔖

Cite This Article

Yıldırım, B., Biltekin, B., Seçilmiş, M., Bilir, A. (2026). COMBINED EFFECTS OF RETINOIC ACID AND SELENIUM ON CELL VIABILITY IN SH-SY5Y NEUROBLASTOMA CELLS. İstanbul Tıp Fakültesi Dergisi, Cilt: 89 Sayı: 2, 127–131. https://doi.org/10.26650/IUITFD.1827318

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (38)

  1. Dos Santos MG, Gomes JR, Costa MDM. Methods used to achieve different levels of the neuronal differentiation process in SH-SY 5Y and Neuro2a cell lines: An integrative review. Cell Biol Int 2023;47(12):1883-94. google scholar
  2. Ioghen OC, Ceafalan LC, Popescu BO. SH-SY5Y cell line ın vitro models for parkinson disease research old practice for new trends. J Integr Neurosci 2023;22(1):20. google scholar
  3. Nguyen HAT, Ho TP, Mangelings D, Van Eeckhaut A, Vander Heyden Y, Tran HTM. Antioxidant, neuroprotective, and neuroblastoma cells (SH-SY5Y) differentiation effects of melanins and arginine-modified melanins from daedaleopsis tricolor and fomes fomentarius. BMC Biotechnology 2024;24(1):89. google scholar
  4. Illendula A, Fultang N, Peethambaran B. Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements. Oncol Rep 2020;44(3):1013-24. google scholar
  5. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, et al. Longterm results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children’s oncology group study. J Clin Oncol 2009;27(7):1007-13. google scholar
  6. Zheng L, Li Z, Wang Z, Shen L, Liu J. The oxidative stress, mitochondrial pathway apoptosis, and the antagonistic effects of chrysophanol in SH-SY5Y cells via DTPP-induced photodynamic therapy. Photodiagnosis Photodyn Ther 2022;40:103062. google scholar
  7. Piras S, Furfaro AL, Brondolo L, Passalacqua M, Marinari UM, Pronzato MA, et al. Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells. Sci Rep 2017;7(1):7568. google scholar
  8. Silvis AM, McCormick ML, Spitz DR, Kiningham KK. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid. Redox Biol 2016;7:88-96. google scholar
  9. Lopez-Suarez L, Awabdh SA, Coumoul X, Chauvet C. The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: Focus on organic pollutants. NeuroToxicology 2022;92:131-55. google scholar
  10. Sarkanen J-R, Nykky J, Siikanen J, Selinummi J, Ylikomi T, Jalonen TO. Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells. J Neurochem 2007;102(6):1941-52. google scholar
  11. Li B, Ming H, Qin S, Nice EC, Dong J, Du Z, et al. Redox regulation: mechanisms, biology and therapeutic targets in diseases. Sig Transduct Target Ther 2025;10(1):72. google scholar
  12. Selvaraj NR, Nandan D, Nair BG, Nair VA, Venugopal P, Aradhya R. Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases. Cells 2025;14(7):511. google scholar
  13. Novotny NM, Grosfeld JL, Turner KE, Rescorla FJ, Pu X, Klaunig JE, et al. Oxidative status in neuroblastoma: a source of stress? J Pediatr Surg 2008;43(2):330-4. google scholar
  14. Jiang H, Zuo J, Li B, Chen R, Luo K, Xiang X, et al. Drug-induced oxidative stress in cancer treatments: Angel or devil? Redox Biology 2023;63:102754. google scholar
  15. Bayeva N, Coll E, Piskareva O. Differentiating neuroblastoma: A systematic review of the retinoic acid, its derivatives, and synergistic interactions. J Pers Med 2021;11(3):211. google scholar
  16. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, et al. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006;58(4):712-25. google scholar
  17. Mehta SL, Kumari S, Mendelev N, Li PA. Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia. BMC Neuroscience 2012;13(1):79. google scholar
  18. Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23(6):815-27. google scholar
  19. Karunakar KK, Cheriyan BV, Babu Devan P, Nandhini J, Suresh Kannan M, et al. Selenium, silver, and gold nanoparticles: Emerging strategies for hepatic oxidative stress and inflammation reduction. Nano TransMed 2025;4:100085. google scholar
  20. Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, Pearson AD, et al. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout. J Natl Cancer Inst 1997;89(6):446-52. google scholar
  21. Liu J, Li J, Zhang J-F, Xin X-Y. Combination of fenretinide and selenite ınhibits proliferation and ınduces apoptosis in ovarian cancer cells. Int J Mol Sci 2013;14(11):21790-804. google scholar
  22. Kim J-S, Kim S-H, Park S-K. Selenocysteine modulates resistance to environmental stress and confers anti-aging effects in C. elegans. Clinics (Sao Paulo) 2016;72(8):491-8 google scholar
  23. Nitti M, Piras S, Lisa Furfaro A, Brondolo L, Maria Marinari U, Adelaide Pronzato M. 231 - neuroblastoma cell response to oxidative stress ıs ımpaired by retinoic acid-ınduced differentiation: Role of HO-1. Free Radic Biol Med 2016;100:S106-7. google scholar
  24. Yıldızhan K, Nazıroğlu M. Protective role of selenium on MPP+ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells. J Recept Signal Transduct Res 2022;42(4):399-408. google scholar
  25. Pifferi A, Chiaino E, Fernandez-Abascal J, Bannon AC, Davey GP, Frosini M, et al. Exploring the Regulation of Cytochrome P450 in SH-SY5Y Cells: Implications for the Onset of Neurodegenerative Diseases. Int J Mol Sci 2024;25(13):7439. google scholar
  26. Andoh T, Chock PB, Chiueh CC. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 2002;277(12):9655-60. google scholar
  27. Andoh T, Chiueh CC, Chock PB. Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis. J Biol Chem 2003;278(2):885-90. google scholar
  28. Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis retinoic acid ınduces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 2006;126(10):2178-89. google scholar
  29. Bilir A, Erguven M, Ermis E, Sencan M, Yazihan N. Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro. J Gynecol Oncol 2011;22(4):225-32. google scholar
  30. Erguven M, Oktem G, Kara AN, Bilir A. Lithium chloride has a biphasic effect on prostate cancer stem cells and a proportional effect on midkine levels. Oncol Lett 2016;12(4):2948-55. google scholar
  31. Aras Y, Erguven M, Aktas E, Yazihan N, Bilir A. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro. Neurol Res 2016;38(9):766-74. google scholar
  32. Conte da Frota ML, Gomes da Silva E, Behr GA, Roberto de Oliveira M, Dal-Pizzol F, Klamt F, et al. All-trans retinoic acid induces free radical generation and modulate antioxidant enzyme activities in rat sertoli cells. Mol Cell Biochem 2006;285(1–2):173-9. google scholar
  33. Gandin V, Khalkar P, Braude J, Fernandes AP. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radic Biol Med 2018;127:80-97. google scholar
  34. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001;475(1–2):123-39. google scholar
  35. Kuršvietienė L, Mongirdienė A, Bernatonienė J, Šulinskienė J, Stanevičienė I. Selenium anticancer properties and ımpact on cellular redox status. Antioxidants 2020;9(1):80. google scholar
  36. Ribeiro MM, Lima LS, da Costa N de S, Pereira ME, Fonseca AS, Cavalli LR, et al. In vitro effects of retinoic acid and sodium selenite on neuroblastoma cell line (SH-SY5Y). Future Pharmacol 2025;5(4):65. google scholar
  37. Misra S, Selvam AK, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all- trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget 2016;7(46):74686-700. google scholar
  38. Ramanauskiene K, Raudonis R, Majiene D. Rosmarinic acid and melissa officinalis extracts differently affect glioblastoma cells. Oxid Med Cell Longev 2016;2016(1):1564257. google scholar